Literature DB >> 35286697

The Immunogenetics of Autoimmune Blistering Diseases.

Diana Kneiber1, Eric H Kowalski1, Kyle T Amber2,3.   

Abstract

Dermatological conditions constituting the group of autoimmune blistering diseases (AIBD) are characterized by loss of immunotolerance and humoral, as well as cellular, autoimmune responses that result in the development of bullae and erosions on the skin and mucous membranes. AIBDs are broadly categorized into pemphigus and pemphigoid classes with several distinct subtypes amongst them. Advances in genetics have allowed for the study and identification of alleles, and even single nucleotide polymorphisms, that harbor increased susceptibility or confer protection for the development of these conditions. The focus of this chapter pertains to a comprehensive review of the known genetic associations with AIBDs, including HLA class I-III, as well as non-HLA genes and non-coding sequences that influence cellular processes and signaling pathways.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Bullous pemphigoid; Epidermolysis bullosa acquisita; Paraneoplastic autoimmune multiorgan syndrome; Pemphigus foliaceus; Pemphigus vulgaris

Mesh:

Year:  2022        PMID: 35286697     DOI: 10.1007/978-3-030-92616-8_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  260 in total

1.  Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion.

Authors:  M Amagai; V Klaus-Kovtun; J R Stanley
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

Review 2.  Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.

Authors:  Erkan Alpsoy; Ayse Akman-Karakas; Soner Uzun
Journal:  Arch Dermatol Res       Date:  2015-01-15       Impact factor: 3.017

Review 3.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 4.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

5.  DR antigens in bullous pemphigoid.

Authors:  A R Ahmed; A Konqui; M S Park; J L Tiwari; P I Terasaki
Journal:  Arch Dermatol       Date:  1984-06

6.  HLA-E*0101/0103X is Associated with Susceptibility to Pemphigus Vulgaris: A Case-control Study.

Authors:  Ece Altun; Savas Yayli; Bayram Toraman; Deniz Aksu Arica; Ersan Kalay; Leyla Baykal Selcuk; Sevgi Bahadir
Journal:  Acta Dermatovenerol Croat       Date:  2017-10       Impact factor: 1.256

7.  Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris.

Authors:  A R Ahmed; E J Yunis; K Khatri; R Wagner; G Notani; Z Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Vesiculobullous eruption in a patient receiving psoralen ultraviolet A (PUVA) treatment for prurigo nodules: a case of PUVA-aggravated pemphigoid nodularis.

Authors:  K T Amber; D Z Korta; S de Feraudy; S A Grando
Journal:  Clin Exp Dermatol       Date:  2017-06-09       Impact factor: 3.470

9.  Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid.

Authors:  A R Ahmed; S Foster; M Zaltas; G Notani; Z Awdeh; C A Alper; E J Yunis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.

Authors:  A Razzaque Ahmed; Srinivas Kaveri
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.